1167 Olaparib in combination with inhibitors of ATR/CHK1 pathway leads to increased cell death in ovarian cancer cells sensitive and resistant to PARPi | Zendy

AI Assistant Blog Pricing

1167 Olaparib in combination with inhibitors of ATR/CHK1 pathway leads to increased cell death in ovarian cancer cells sensitive and resistant to PARPi

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.